- Previous close
48.61 - Open
48.32 - Bid 47.82 x 900
- Ask 49.49 x 1000
- Day's range
48.67 - 49.35 - 52-week range
47.71 - 68.72 - Volume
22,634 - Avg. Volume
1,283,259 - Market cap (intra-day)
6.161B - Beta (5Y monthly) 0.85
- PE ratio (TTM)
4.05 - EPS (TTM)
12.19 - Earnings date 4 Feb 2025
- Forward dividend & yield 2.32 (4.77%)
- Ex-dividend date 31 Dec 2024
- 1y target est
70.62
FMC Corporation, an agricultural sciences company, provides crop protection, plant health, and professional pest and turf management products. It develops, markets, and sells crop protection chemicals that includes insecticides, herbicides, and fungicides; and biologicals, crop nutrition, and seed treatment products, which are used in agriculture to enhance crop yield and quality by controlling a range of insects, weeds, and diseases, as well as in non-agricultural markets for pest control. The company markets its products through its own sales organization and through alliance partners, independent distributors, and sales representatives. It operates in North America, Latin America, Europe, the Middle East, Africa, and Asia. The company was founded in 1883 and is headquartered in Philadelphia, Pennsylvania.
www.fmc.com5,800
Full-time employees
31 December
Fiscal year ends
Basic Materials
Sector
Agricultural Inputs
Industry
Recent news: FMC
View more
Performance overview: FMC
Trailing total returns as of 02/01/2025, which may include dividends or other distributions. Benchmark is
.YTD return
1-year return
3-year return
5-year return
Compare to: FMC
Select to analyse similar companies using key performance metrics; select up to four stocks.
Statistics: FMC
View moreValuation measures
Market cap
6.07B
Enterprise value
9.72B
Trailing P/E
3.99
Forward P/E
10.44
PEG ratio (5-yr expected)
--
Price/sales (ttm)
1.46
Price/book (mrq)
1.32
Enterprise value/revenue
2.33
Enterprise value/EBITDA
21.54
Financial highlights
Profitability and income statement
Profit margin
34.93%
Return on assets (ttm)
2.83%
Return on equity (ttm)
38.45%
Revenue (ttm)
4.17B
Net income avi to common (ttm)
1.53B
Diluted EPS (ttm)
12.19
Balance sheet and cash flow
Total cash (mrq)
416.7M
Total debt/equity (mrq)
90.93%
Levered free cash flow (ttm)
600.19M